Modeling mortality risk in patients with severe COVID-19 from Mexico
- PMID: 37324144
- PMCID: PMC10263446
- DOI: 10.3389/fmed.2023.1187288
Modeling mortality risk in patients with severe COVID-19 from Mexico
Abstract
Background: Severe acute respiratory syndrome caused by a coronavirus (SARS-CoV-2) is responsible for the COVID-19 disease pandemic that began in Wuhan, China, in December 2019. Since then, nearly seven million deaths have occurred worldwide due to COVID-19. Mexicans are especially vulnerable to the COVID-19 pandemic as Mexico has nearly the worst observed case-fatality ratio (4.5%). As Mexican Latinos represent a vulnerable population, this study aimed to determine significant predictors of mortality in Mexicans with COVID-19 who were admitted to a large acute care hospital.
Methods: In this observational, cross-sectional study, 247 adult patients participated. These patients were consecutively admitted to a third-level referral center in Yucatan, Mexico, from March 1st, 2020, to August 31st, 2020, with COVID-19-related symptoms. Lasso logistic and binary logistic regression were used to identify clinical predictors of death.
Results: After a hospital stay of about eight days, 146 (60%) patients were discharged; however, 40% died by the twelfth day (on average) after hospital admission. Out of 22 possible predictors, five crucial predictors of death were found, ranked by the most to least important: (1) needing to be placed on a mechanical ventilator, (2) reduced platelet concentration at admission, (3) increased derived neutrophil to lymphocyte ratio, (4) increased age, and (5) reduced pulse oximetry saturation at admission. The model revealed that these five variables shared ~83% variance in outcome.
Conclusion: Of the 247 Mexican Latinos patients admitted with COVID-19, 40% died 12 days after admission. The patients' need for mechanical ventilation (due to severe illness) was the most important predictor of mortality, as it increased the odds of death by nearly 200-fold.
Keywords: COVID-19; Mexico; SARS-CoV-2; disparities; modeling; mortality; prediction; underserved.
Copyright © 2023 Cortes-Telles, Figueroa-Hurtado, Ortiz-Farias and Zavorsky.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment in
-
Commentary: Modeling mortality risk in patients with severe COVID-19 from Mexico.Front Med (Lausanne). 2023 Sep 28;10:1247741. doi: 10.3389/fmed.2023.1247741. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37840999 Free PMC article. No abstract available.
-
Response: Commentary: Modeling mortality risk in patients with severe COVID-19 from Mexico.Front Med (Lausanne). 2023 Nov 21;10:1301349. doi: 10.3389/fmed.2023.1301349. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38076246 Free PMC article. No abstract available.
Similar articles
-
Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.Lancet Reg Health Am. 2022 Apr;8:100177. doi: 10.1016/j.lana.2021.100177. Epub 2022 Jan 7. Lancet Reg Health Am. 2022. PMID: 35018359 Free PMC article.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.Ann Emerg Med. 2020 Oct;76(4):394-404. doi: 10.1016/j.annemergmed.2020.05.011. Epub 2020 May 11. Ann Emerg Med. 2020. PMID: 32563601 Free PMC article.
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. PMID: 32406927 Free PMC article. Updated.
-
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270. JAMA Netw Open. 2020. PMID: 32543702 Free PMC article. Review.
Cited by
-
Development and evaluation of a mechanical ventilator-sharing system.Front Med (Lausanne). 2024 Feb 16;11:1356769. doi: 10.3389/fmed.2024.1356769. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38435386 Free PMC article.
-
Commentary: Modeling mortality risk in patients with severe COVID-19 from Mexico.Front Med (Lausanne). 2023 Sep 28;10:1247741. doi: 10.3389/fmed.2023.1247741. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37840999 Free PMC article. No abstract available.
-
Response: Commentary: Modeling mortality risk in patients with severe COVID-19 from Mexico.Front Med (Lausanne). 2023 Nov 21;10:1301349. doi: 10.3389/fmed.2023.1301349. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38076246 Free PMC article. No abstract available.
References
-
- John Hopkins University & Medicine . COVID-19 DASHBOARD by the Center for Sytems Science and Engineering (CSSE) John Hopkins university. Coronavirus resource center Available at: https://coronavirus.jhu.edu/map.html
-
- John Hopkins University & Medicine . Mortality in the 20 most affected countries worldwide John Hopkins university. Coronavirus resource center Available at: https://coronavirus.jhu.edu/data/mortality
-
- Nyasulu PS, Ayele BT, Koegelenberg CF, Irusen E, Lalla U, Davids R, et al. . Clinical characteristics associated with mortality of COVID-19 patients admitted to an intensive care unit of a tertiary hospital in South Africa. PLoS One. (2022) 17:e0279565. doi: 10.1371/journal.pone.0279565, PMID: - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous